{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T08:08:17Z","timestamp":1776499697589,"version":"3.51.2"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN 503143"],"award-info":[{"award-number":["RGPIN 503143"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Data in Brief"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.dib.2024.111182","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T21:40:44Z","timestamp":1733348444000},"page":"111182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Data characterizing a panel of biodegradable cross-linked polyester implants for sustained delivery of an anti-viral drug"],"prefix":"10.1016","volume":"58","author":[{"given":"Sungmin","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Bufton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeqing","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wonjoon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4916-3965","authenticated-orcid":false,"given":"Christine","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dib.2024.111182_bib0001","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.addr.2020.11.008","article-title":"Clinically established biodegradable long acting injectables: an industry perspective","volume":"167","author":"Nkanga","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.dib.2024.111182_bib0002","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1016\/S2352-3018(19)30342-X","article-title":"Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIV","volume":"7","author":"Bollinger","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.dib.2024.111182_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.569373","article-title":"Multispecies evaluation of a long-acting tenofovir alafenamide subdermal implant for HIV prophylaxis","volume":"11","author":"Gunawardana","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.dib.2024.111182_bib0004","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3390\/pharmaceutics11070315","article-title":"Characterization of a reservoir-style implant for sustained release of tenofovir alafenamide (TAF) for HIV pre-exposure prophylaxis (PrEP)","volume":"11","author":"Johnson","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.dib.2024.111182_bib0005","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/pharmaceutics12111057","article-title":"Performance and stability of tenofovir alafenamide formulations within subcutaneous biodegradable implants for HIV pre-exposure prophylaxis (PrEP)","volume":"12","author":"Li","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.dib.2024.111182_bib0006","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.01893-19","article-title":"A subcutaneous implant of tenofovir alafenamide fumarate causes local inflammation and tissue necrosis in rabbits and macaques","volume":"64","author":"Su","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.dib.2024.111182_bib0007","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jconrel.2018.08.010","article-title":"Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis","volume":"286","author":"Chua","year":"2018","journal-title":"J. Controll. Rel."},{"key":"10.1016\/j.dib.2024.111182_bib0008","doi-asserted-by":"crossref","first-page":"8224","DOI":"10.1038\/s41598-022-11020-2","article-title":"Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxis","volume":"12","author":"Gunawardana","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.dib.2024.111182_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105808","article-title":"Cross-linked valerolactone copolymer implants with tailorable biodegradation, loading and in vitro release of paclitaxel","volume":"162","author":"Bufton","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.dib.2024.111182_bib0010","article-title":"Physico-chemical characterization of a panel of cross-linked polyester implants","volume":"v1","author":"Jung","year":"2024","journal-title":"Mendeley Data"}],"container-title":["Data in Brief"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352340924011442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352340924011442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:10:31Z","timestamp":1762618231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352340924011442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":10,"alternative-id":["S2352340924011442"],"URL":"https:\/\/doi.org\/10.1016\/j.dib.2024.111182","relation":{"is-supplemented-by":[{"id-type":"uri","id":"https:\/\/data.mendeley.com\/datasets\/jmd69fbd94\/1","asserted-by":"subject"}]},"ISSN":["2352-3409"],"issn-type":[{"value":"2352-3409","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Data characterizing a panel of biodegradable cross-linked polyester implants for sustained delivery of an anti-viral drug","name":"articletitle","label":"Article Title"},{"value":"Data in Brief","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dib.2024.111182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111182"}}